Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;11(1):62-68.
doi: 10.1002/jcsm.12503. Epub 2019 Dec 30.

Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants

Affiliations

Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants

Richard M Dodds et al. J Cachexia Sarcopenia Muscle. 2020 Feb.

Abstract

Background: Sarcopenia, the loss of muscle strength and mass, predicts adverse outcomes and becomes common with age. There is recognition that sarcopenia may occur at younger ages in those with long-term conditions (LTCs) as well as those with multimorbidity (the presence of two or more LTCs), but their relationships have been little explored. Our aims were to describe the prevalence of sarcopenia in UK Biobank, a large sample of men and women aged 40-70 years, and to explore relationships with different categories of LTCs and multimorbidity.

Methods: We used data from 499 046 participants in the baseline of UK Biobank. Our main outcome was probable sarcopenia based on maximum grip strength below sex-specific cut-points. Participants' LTCs were recorded during an interview and categorized against a hierarchy. We used logistic regression to examine the independent associations between each category of LTCs and probable sarcopenia, including adjustment for age, sex, and body mass index. We also examined the association with multimorbidity.

Results: Probable sarcopenia had an overall prevalence of 5.3% and increased with age. The categories with the strongest associations with probable sarcopenia were musculoskeletal/trauma [OR 2.17 (95% CI: 2.11, 2.23)], endocrine/diabetes [OR 1.49 (95% CI: 1.45, 1.55)], and neurological/psychiatric [OR 1.39 (95% CI: 1.34, 1.43)] LTCs. Almost half of the sample (44.5%) had multimorbidity, and they were at nearly twice the odds of probable sarcopenia [OR 1.96 (95% CI: 1.91, 2.02)] compared with those without.

Conclusions: We have shown an overall prevalence of 5.3% of probable sarcopenia at ages 40-70 in UK Biobank. The risk of probable sarcopenia was higher in those with some categories of LTCs, suggesting that these groups may stand to benefit from assessment of sarcopenia, during mid-life as well as old age.

Keywords: Grip strength; Later life; Long-term conditions; Mid-life; Multimorbidity; Sarcopenia.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Independent associations between probable sarcopenia and each category of chronic conditions. Findings from logistic regression model showing independent associations between having one or more chronic conditions in each category and probable sarcopenia. Other variables in model (not shown): age (as linear term), sex, and body mass index category. N = 499 046. ENT, ear nose and throat.
Figure 2
Figure 2
Prevalence of probable sarcopenia by age and number of categories of conditions. The prevalence of probable sarcopenia is shown for each combination of age group and number of categories of chronic conditions. Men and women combined, N = 499 046.

References

    1. Celis‐Morales CA, Welsh P, Lyall DM, Steell L, Petermann F, Anderson J, Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ 2018;k1651:361. - PMC - PubMed
    1. Landi F, Cruz‐Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing 2013;42:203–209. - PubMed
    1. Aihie Sayer A, Robinson SM, Patel HP, Shavlakadze T, Cooper C, Grounds MD. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing 2013;42:145–150. - PMC - PubMed
    1. Cruz‐Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16–31. - PMC - PubMed
    1. Cruz‐Jentoft AJ, Sayer AA. Sarcopenia. Lancet; 2019. - PubMed

Publication types